What is Umeclidinium?

Category: Prescription Drugs

Most popular types: Incruse Ellipta

false

Umeclidinium is a long-term, once-daily, maintenance treatment for patients with chronic obstructive pulmonary disease, chronic bronchitis, and/or emphysema.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Chronic obstructive pulmonary disease 10 6
Bronchitis 1 1
Mycobacterium avium complex 1 1
Reactive airways dysfunction syndrome 1 1

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 1
Mild 0
None 7

Commonly reported side effects and conditions associated with Umeclidinium

Side effect Patients Percentage
Breathing difficulty 1
Chronic constipation 1

Dosages

Based on patients currently taking Umeclidinium

Dosage Patients Percentage
62.5 mcg daily 5

Why patients stopped taking Umeclidinium

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 1
See 1 patient who's stopped taking Umeclidinium

Duration

Currently taking Umeclidinium

Duration Patients Percentage
1 - 6 months 1
1 - 2 years 2
2 - 5 years 2

Stopped taking Umeclidinium

Duration Patients Percentage
Less than 1 month 1
2 - 5 years 1
Adherence
Adherence Evaluations Percentage
Always 3
Usually 5
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 1
A little hard to take 1
Not at all hard to take 6
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 2
$50-99 1
$25-49 0
< $25 3
Not specified 2

What people switch to and from

Patients started taking Umeclidinium after stopping:

Treatment Patients Percentage
Fluticasone-Salmeterol (Advair Diskus) 2
Tiotropium inhaler (Spiriva HandiHaler) 2
Aclidinium Bromide (Tudorza Pressair) 1
Budesonide-Formoterol (Symbicort) 1
Ipratropium (Ipratropium Inhalant) 1

Show all 7 treatments patients report switching from

Patients stopped taking Umeclidinium and switched to:

Treatment Patients Percentage
Aclidinium Bromide (Tudorza Pressair) 1
Amoxicillin (Amoxil) 1
Budesonide-Formoterol (Symbicort) 1
Last updated:
There are no evaluations for Umeclidinium.